Back to results
US 2024/0390477 A1Published application
J paramyxovirus vaccines
AssigneeUniversity of Georgia Research Foundation, Inc.
InventorBiao He
Life of this patent
Estimating the term…
Abstract
The present invention provides safe, stable, efficacious, and cost-effective vaccines based on viral expression vectors that include a J Paramyxovirus (JPV) genome including a heterologous nucleotide sequence expressing a heterologous polypeptide inserted within the JPV genome.
Claims25
A viral expression vector comprising a J Paramyxovirus (JPV) genome comprising a heterologous nucleotide sequence expressing a heterologous polypeptide inserted within the JPV genome.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.